Amgen profit tops Street view, boosts full-year forecast

July 30, 2015 8:14 PM

36 0

Amgen profit tops Street view, boosts full-year forecast

Amgen Inc (AMGN.O) on Thursday reported higher-than-expected second quarter profit and revenue, helped by strong sales of its Enbrel rheumatoid arthritis drug and cost cutting, and the company raised its full-year forecasts.

The world's largest biotechnology company said net profit rose to $1.65 billion, or $2.15 per share, from $1.55 billion, or $2.01, a year ago.

Also read: UPDATE 1-Industrial equipment hire firm Ashtead hikes annual results forecast

Read more

To category page

Loading...